Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Managing Side Effects Side effects with Retatrutide are primarily gastrointestinal and tend to be temporary
The highest dose group showed the greatest weight loss
I found on GoodRx.com and another cash pay website that they can actually offer some of those first line medications like Wegovy and semiglutide for 99 dollars to 129 dollars per month at a cash rate
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity." NEJM 2023;389:514526 FDA Prescription Drug User Fee Act (PDUFA) Guidelines FDA Center for Drug Evaluation and Research (CDER): NDA review process ClinicalTrials.gov: TRIUMPH Phase 3 program trial registry Historical obesity drug approval precedents: Semaglutide, Tirzepatide, Liraglutide Frequently Asked Questions Based on the current timeline, retatrutide FDA approval is expected in late 2027 to Q1 2028
Liu Z, Zhang M, Zhou T, Shen Q, Qin X
Over time, it can lead to additional health problems and complications
US$ 26.56
US$ 21.60
US$ 24.86
US$ 26.19
US$ 26.77
